Navigation Links
Althea Technologies Receives FDA Approval to Initiate Commercial Manufacturing
Date:6/27/2011

SAN DIEGO, June 28, 2011 /PRNewswire/ -- Althea Technologies, Inc. announced today that following a comprehensive FDA Pre-Approval Inspection (PAI) in April 2011, it has received a license to manufacture and package a commercial parenteral product for the US market.  The product will be filled and packaged at the company's new, state-of-the-art commercial manufacturing facility located in San Diego, California.  This facility, the third on Althea's campus, was constructed to accommodate the increased demand the company has experienced in both its drug product and biologics manufacturing business units. To support this growth, the company has also expanded its analytical development, stability testing and formulation development capabilities for larger clinical and commercial projects.  

"We are very pleased with the successful outcome of our initial PAI and anticipate working with our clients to bring several other products to commercialization over the coming months," stated Rick Hancock, President of Althea Technologies.  "Our entire team feels very gratified to have achieved this major milestone.  This accomplishment is the result of thoughtful and diligent investment in expanding our quality systems, facilities and operational capabilities in a climate that has been challenging for many companies in our industry."

In the past 12 months, Althea has installed and validated a fully-automated, INOVA H3-5 syringe filling line that can accommodate high viscosity and shear sensitive products.  This line can accommodate a wide variety of glass or plastic syringes and cartridges in batch sizes exceeding 100,000 units and is a critical component of the company's expansion in commercial manufacturing.

Althea Technologies will be exhibiting at the BIO International Convention.  Please visit us at Booth #1637.

About Althea Technologies, Inc.

Althea Technologies is a fully integrated, contract development and manufacturing organization located in San Diego, CA providing clinical and commercial product development services.  Althea offers cGMP drug product filling in both vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA.   In conjunction with these manufacturing operations, Althea offers comprehensive development services including:  upstream and downstream process development, analytical development, lyophilisation cycle and formulation development, product release and ICH-compliant stability testing.  Althea's formulation technology platform includes Crystalomics, a technology that offers a formulation solution for large molecule products that must be delivered at high concentrations or as sustained release formulations.  For more information, visit www.altheatech.com.


'/>"/>
SOURCE Althea Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea and Biotest Establish Commercial Filling Agreement
2. Althea Technologies Announces Appointment of Rick Hancock as President
3. Althea Technologies Announces the Installation of a High-Speed Prefilled Syringe Line
4. Althea Technologies Acquires Altus Pharmaceuticals(R) Assets and IP Portfolio, Establishing Technology Platform for Protein Formulations.
5. Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
6. Global Technologies, Ltd. Announces LOI to Acquire and Merge with Oxygen Orchard, Inc.
7. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
8. Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K.
9. China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health
10. Andrew Technologies Names Tom Albright CEO and Board Member
11. BioSpecifics Technologies Corp. Announces Board Authorization of up to $2 Million Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
(Date:2/27/2017)... The Dutch secure mobile phone ... at the security level RESTRICTED. The solution thus meets the ... the communication of classified information. ... Sectra and Samsung have a strategic ... solution. Sectra Tiger/R is developed by Sectra under guidance from ...
(Date:2/24/2017)... Research and Markets has announced the addition ... Industry Forecast to 2025" report to their offering. ... The Global Wireless Health ... over the next decade to reach approximately $330.5 billion by 2025. ... for all the given segments on global as well as regional ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... This ... became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p ... ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for the ...
(Date:2/26/2017)... ... ... IndustryArchive.Org . is announcing a new way for B2B Sellers to promote ... for B.A.N.T. quality sales leads based on the Sellers decision to purchase a sales ... B2B buyers are controlling the sales process via the Internet and that ad targeting ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports ... a study released today at the 1st Pan American Parkinson’s and Movement Disorders ... be effective in improving cognitive function in PD patients. This study, led by ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, expert standing desk solution ... advantages built into the home office sit stand solution are bold colors, a ... gain the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... education, networking and recognition opportunities as well as advocacy for the state and ... NJ on February 23. The Council's Innovation Forecast event highlights innovation throughout ...
Breaking Medicine News(10 mins):